NCT02288975View on ClinicalTrials.gov

Adsorbtion of Cytokines Early in Septic Shock: the ACESS Study

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
SepsisSeptic Shock
Interventions
DEVICE

CytoSorb 300ml device (3804606CE01)

Trial Locations (1)

H-6725

Department of Anaesthesiology and Intensive Therapy, Szeged

All Listed Sponsors
lead

Zsolt Molnár, MD, PhD, DEAA

OTHER

NCT02288975 - Adsorbtion of Cytokines Early in Septic Shock: the ACESS Study | Biotech Hunter | Biotech Hunter